Compounded GLP-1 Delivery and Subscription: Shipping Explained
Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality. Compounded semaglutide and tirzepatide are not the same as brand-name products such as Wegovy or Zepbound and may differ in formulation, purity, and potency.
Once you are seriously considering a compounded GLP-1 program, the practical questions come quickly: how does the medication actually reach me, is this a subscription I am locked into, and what do I do when the box shows up? This page walks through how compounded semaglutide and tirzepatide are usually delivered, what to check about a monthly program, how refills and renewals tend to work, and what to do the moment your medication arrives.
Transformation Health is an independent guide. We do not prescribe, compound, sell, or ship medication. The program and pharmacy you choose handle all of that, so the questions below are the ones to ask them.
How your medication reaches your door
Delivery is the last step of a prescription-based process, not a retail purchase. Here is how it usually works at a legitimate telehealth program.
Step 1: Prescription
At most telehealth programs, a licensed provider reviews your health history and decides whether a compounded GLP-1 medication is appropriate. Nothing should ship until this clinical step is done.
Step 2: Pharmacy preparation
If a prescription is written, it goes to a state-licensed compounding pharmacy, which prepares the medication for your order. Ask which pharmacy the program uses.
Step 3: Shipped to you
The pharmacy packages the medication, usually in insulated packaging with cold packs, and ships it to your home. Ask whether injection supplies are included.
Step 4: Arrives and stored
Your package arrives by mail or courier. You bring it inside promptly, store it as the pharmacy label directs, and follow the prescriber's instructions for starting.
Before your first shipment, it is worth asking the program or pharmacy a few direct questions:
- How is it packed? What insulation and cold packs are used, and how many days in transit is the packaging designed to protect the medication?
- When does it ship? Does the pharmacy avoid shipping right before weekends or holidays, when a package could sit in a warehouse?
- What about hot weather? Does the pharmacy change its packaging or shipping method in summer or for hot regions?
- Is a signature required, and is there tracking?
- Who do I call if it arrives warm or damaged, and will it be replaced?
- What is included? Syringes, needles, alcohol pads, and a sharps container are included at some programs and extra at others.
- What storage instructions and beyond-use date will be on the label?
For a closer look at the logistics from prescription to doorstep, see how medication shipping works.
Is it a subscription?
At many programs, it works like a monthly subscription rather than a one-time purchase. The details vary by program, so check each of these before you pay:
- The billing cycle. Is it billed monthly, per shipment, or prepaid for several months? Does the price change as the dose increases?
- What one payment covers. Some fees bundle the medication, provider visits, labs, and shipping. Others cover the medication only and bill the rest separately.
- Commitment and cancellation. Is there a minimum term? Does it renew automatically? How do you cancel, and what happens to a shipment the pharmacy has already started preparing?
- Ongoing care. Does a licensed provider follow up during treatment, and is that included or extra? A program that ships medication with no follow-up is skipping something that matters for your safety.
A recurring schedule exists for a practical reason. GLP-1 treatment involves consistent weekly dosing and periodic check-ins, so a program that times shipments to your doses helps you avoid gaps.
Program options to review
Programs differ in what they bundle and how they bill, so a low headline number can turn into a higher real cost once labs, visits, or shipping are added. Prices vary by program and dose and change often. Compare the total cost: the medication at your likely dose, dose increases, provider visits, labs, shipping, membership fees, and cancellation terms.
Ask each program one direct question: does the monthly price include the medication, lab work, ongoing provider care, and shipping, at my starting dose and at higher doses? If a program will not answer that clearly, keep looking. For a fuller breakdown of what drives the price, see the compounded semaglutide cost guide and compounded tirzepatide cost.
Transformation Health does not accept payment from providers. How we make money.
How refills and renewals work
After your first shipment, refills at most programs continue on a schedule as long as your prescription is active and the prescriber agrees that continuing is appropriate. This is where a compounded GLP-1 program differs from ordering a product once:
- Scheduled shipments. Refills are usually timed to your dosing so there is no gap between deliveries when everything is on track. Ask how far ahead of your last dose the next shipment goes out.
- Provider check-ins. Many providers review your progress periodically, and may look at updated lab work before renewing. This is a normal part of safe care, not a delay tactic.
- Dose changes. If the prescriber decides your dose should change, that decision should be made before the next shipment so the pharmacy prepares the right strength.
You can read more about the clinical side of this in our guide to prescription renewal.
When your medication arrives
How you handle the package on arrival matters, especially for temperature-sensitive medication.
Bring it inside promptly. Do not leave the package sitting outside longer than necessary. If you know you will be away, ask whether the delivery date can be changed.
Check the shipment before you store it. Look at the cold packs and the medication. If the package arrived warm, the packaging is damaged, or the medication appears to have frozen, set it aside and call the dispensing pharmacy before using it rather than guessing. Both the Zepbound and Wegovy labels say not to use the medication if it has been frozen[3][4].
Store it as the pharmacy label directs. For compounded medication, the storage instructions and beyond-use date come from the pharmacy that prepared it, and they vary by formulation and pharmacy. Once a compounded multi-dose vial is first punctured, USP sterile compounding standards say it must not be used for longer than 28 days or its beyond-use date, whichever comes first[5]. Some pharmacies set a shorter limit. Write the date you first open the vial on the label.
Brand-name label windows are not compounded rules. You may see room-temperature limits quoted online. These come from the FDA labels for the brand-name products. On the Zepbound label, single-dose pens and vials can be kept unrefrigerated at up to 86F for a total of 21 days[3]. On the Wegovy label, single-dose pens can be kept between 46F and 86F for up to 28 days before the cap is removed[4]. These windows describe the brand-name products and may not apply to a compounded medication. Our guide on how to store GLP-1 medication covers refrigeration, room-temperature limits, and in-use windows in more detail.
Traveling? If you need to take your medication with you, our guide on traveling with GLP-1 medication explains how to keep it protected on the road.
Availability can change
One honest caveat about relying on ongoing delivery: whether a pharmacy may compound semaglutide or tirzepatide depends on federal and state pharmacy law and on FDA policy. On December 19, 2024, FDA determined that the tirzepatide injection shortage was resolved, and on February 21, 2025, it determined the same for semaglutide injection[2]. FDA has posted later updates to its compounding policy, most recently dated April 1, 2026; check the FDA page for the current statement[2]. Continued availability is not guaranteed. If supply changes, ask the prescriber about your options. You can read the current picture in is compounded GLP-1 still available.
State requirements
Where you live can affect both the prescription and the shipment. Telehealth rules differ by state, and some programs require a live video visit before prescribing in certain states. If you are asked to schedule one, it is a normal requirement, not a problem with your request.
Before you pay, ask two questions: is the provider licensed in the state where you live, and is the pharmacy licensed or registered to ship to patients in your state? You can check a pharmacy’s license with your state board of pharmacy, and for an outsourcing facility, on FDA’s list of registered outsourcing facilities. For more on checking a source, see how to choose a safe compounding pharmacy.
We're relaunching soon
We're relaunching as an independent GLP-1 guide. Leave your email and we'll let you know when your free custom report is ready.
Get StartedImportant disclosures
Compounded semaglutide and tirzepatide are not FDA-approved. The FDA does not review compounded medications for safety, effectiveness, or quality[1], and compounded products differ from brand-name products, which went through FDA review. Compounded semaglutide and tirzepatide are not the same as Wegovy or Zepbound and may differ in formulation, purity, and potency, so you cannot assume they will produce the same results.
Regulatory status can change. Compounding of semaglutide and tirzepatide depends on FDA policy and on state and federal pharmacy compounding law. Dates and current status are in the section above and on the FDA page cited there[2]. Availability cannot be guaranteed.
Individual results vary, and weight loss is not guaranteed. How much weight a person loses depends on many factors, including starting weight, age, metabolism, adherence, diet, exercise, sleep, and overall health. A licensed provider can help you understand what a realistic outcome looks like for your situation.
Storage and beyond-use instructions differ by product and pharmacy. Follow the label and the written instructions that come with your medication.
Citations
[1] U.S. Food and Drug Administration. “Compounding and the FDA: Questions and Answers.” Content current as of 09/16/2025. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers (Accessed 2026-10-16. Compounded drugs are not FDA-approved; FDA does not verify their safety, effectiveness, or quality.)
[2] U.S. Food and Drug Administration. “FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize.” Content current as of 04/01/2026. https://www.fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize (Accessed 2026-10-16. Tirzepatide shortage resolved December 19, 2024; semaglutide shortage resolved February 21, 2025.)
[3] U.S. Food and Drug Administration. ZEPBOUND (tirzepatide) injection, prescribing information, section 16.2 Storage and Handling. Revised 08/2026. https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/217806Orig1s041correctedlbl.pdf
[4] U.S. Food and Drug Administration. WEGOVY (semaglutide) injection and tablets, prescribing information, section 16 Storage and Handling. Revised 06/2026. https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/215256s025lbl.pdf
[5] United States Pharmacopeia (USP). “797 FAQs.” Updated December 11, 2023 (questions 193-194, multiple-dose CSPs). https://pages.usp.org/rs/711-SXF-172/images/USP_HQS_797_FAQs_December2023_V6__002.pdf
Important: This content is for general education and is not medical advice. Talk with a licensed provider about your situation. Transformation Health is an independent GLP-1 guide. It does not provide medical care, prescribe, compound, sell, or ship medication. A licensed provider decides whether a prescription is appropriate. Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality. Compounded semaglutide and tirzepatide are not the same as brand-name products such as Wegovy or Zepbound and may differ in formulation, purity, and potency. Results vary. Availability of compounded GLP-1 medications depends on FDA policy and applicable state and federal pharmacy compounding laws, which may change. Wegovy is a trademark of Novo Nordisk A/S. Zepbound is a trademark of Eli Lilly and Company. Transformation Health is not affiliated with or endorsed by these companies. Transformation Health does not accept payment from providers. How we make money.